U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 4

1.
Figure 1

Figure 1. From: Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer.

Flow chart of search strategy.

Ping Gong, et al. Medicine (Baltimore). 2018 Nov;97(46):e13204.
2.
Figure 2

Figure 2. From: Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer.

Forest plot of hazard ratio for the association of tasquinimod and radiologic progression-free survival.

Ping Gong, et al. Medicine (Baltimore). 2018 Nov;97(46):e13204.
3.
Figure 3

Figure 3. From: Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer.

Forest plot of hazard ratio for the association of tasquinimod and AEs. A = All AEs, B = decreased appetite, C = nausea, D = fatigue, E = constipation, F = anemia, G = asthenia, H = decreased weight, I = back pain, J = pain in extremity, K = arthralgia, L = diarrhea, M = insomnia, N = vomiting, O = peripheral edema.

Ping Gong, et al. Medicine (Baltimore). 2018 Nov;97(46):e13204.
4.
Figure 3 (Continued)

Figure 3 (Continued). From: Efficacy of tasquinimod in men with metastatic castration-resistant prostate cancer.

Forest plot of hazard ratio for the association of tasquinimod and AEs. A = All AEs, B = decreased appetite, C = nausea, D = fatigue, E = constipation, F = anemia, G = asthenia, H = decreased weight, I = back pain, J = pain in extremity, K = arthralgia, L = diarrhea, M = insomnia, N = vomiting, O = peripheral edema.

Ping Gong, et al. Medicine (Baltimore). 2018 Nov;97(46):e13204.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center